Matches in Nanopublications for { ?s ?p "[Vasoactive intestinal peptide (VIP) has been considered as a promising drug candidate for asthma and COPD because of its potent immunomodulating and anti-inflammatory activities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP43377.RAUBOzBEUn3B3h1yyYKp4H0OSXicjG9_gbE04n-UkIPm0130_assertion description "[Vasoactive intestinal peptide (VIP) has been considered as a promising drug candidate for asthma and COPD because of its potent immunomodulating and anti-inflammatory activities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP43377.RAUBOzBEUn3B3h1yyYKp4H0OSXicjG9_gbE04n-UkIPm0130_provenance.
- NP64312.RA4Bf98K-fexeHTj8vXyWWWIlaavJaPGiXlQcvjPZwdUU130_assertion description "[Vasoactive intestinal peptide (VIP) has been considered as a promising drug candidate for asthma and COPD because of its potent immunomodulating and anti-inflammatory activities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64312.RA4Bf98K-fexeHTj8vXyWWWIlaavJaPGiXlQcvjPZwdUU130_provenance.